Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 4, 2002, Pages 973-976

  Poggi, Sarah H ^a   Vink, Joy ^b   Goodwin, Katie ^b   Hill, Joanna M ^b   Brenneman, Douglas E ^b   Pinhasov, Albert ^b   Gozes, Illana ^c   Spong, Catherine Y ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Activity dependent neuroprotective protein; Embryonic growth; Mouse; Vasoactive intestinal peptide

Indexed keywords

ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN; IMMUNOGLOBULIN ANTIBODY; MESSENGER RNA; NEUROPROTECTIVE AGENT; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DECIDUA; EMBRYO DEVELOPMENT; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NERVE CELL; NEUROPROTECTION; NIDATION; NONHUMAN; ORGANOGENESIS; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036795845     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.127141     Document Type: Conference Paper

References (17)

1. Bassan M, Zamostiano R, Davidson A, Pihasov A, Giladi E, Peri O, et al. Complete sequence of a novel protein containing a femtomolar-activity dependent neuroprotective protein. J Neurochem 1999;72:1283-93.
2. Gressens P, Hilll JM, Gozes I, Ridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 1993;362:155-8.
3. Gressens P, Hill JM, Paindaveine B, Gozes I, Fridkin M, Brenneman DE. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroeptihelium of the mouse. J Clin Invest 1994;94:2020-7.
4. Hill JM, Agoston DV, Gressens P, McCune SK. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic effects. J Comp Neurol 1994;342:186-205.
5. Hill JM, McCune SK, Alvero RJ, Glazner GW, Henins KA, Stanziale SF, et al. Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent. J Clin Invest 1996;97:202-8.
6. Gressens P, Paindaveine B, Hill JM, Evrard P, Brenneman DE. Vasoactive intestinal peptide shortens both G1 and S phases of cell cycle in whole cultured mouse embryos. Eur J Neurosci 1998;10:1734-42.
7. Hill JM, Lee SJ, Dibbern DA, Fridkin M, Gozes I, Brenneman DE. Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth. Neuroscience 1999;93:783-91.
8. Brenneman DE, Nicol T, Warren D, Bowers LM. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J Neurosci Res 1990;25:386-94.
9. Brenneman DE, Hill JM, Glazner GW, Gozes I, Phillips TW. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. In J Dev Neurosci 1995;13:187-200.
10. Brenneman DE, Hauser J, Spong CY, Phillips TM, Pert CB, Ruff M. VIP and D-ala peptide T-amide release chemokines which prevent HIV-1 GP 120-induced neuronal death. Brain Res 1999;838:27-36.
11. Spong CY, Lee SJ, McCune AK, Gibney G, Abebe DT, Alvero R, et al. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 1999;140:917-24.
12. Zamiastono R, Pinhazov A, Gelber E, Steingart RA, Seroussi E, Giladi E, et al. Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem 2000;276:708-14.
13. Gozes I, Fridkin M, Hill JM, Brenneman DE. Pharmaceutical VIP: prospects and problems. Curr Med Chem 1999;6:1019-34.
14. Heyborn KD, Cranfill BL, Carding SR, Born WK, O'Brien RL. Characterization of yδ T cells at the maternal fetal interface. J Immunol 1992;149:2972-8.
15. Beni-Adani L, Gozes I, Cohen Y, Assaf Y, Steingart R, Brenneman DE, et al. A peptide derived from activity dependent neuroprotective protein ameliorates injury response in closed head injury in mice. J Pharm Exp Ther 2001;296:57-63.
16. Spong CY, Abebe DT, Gozes I, Brenneman DE, Hill JM. Prevention of fetal demise and growth restriction a mouse model of fetal alcohol syndrome. J Pharm Exp Ther 2001;297:774-9.
17. Spong C, Vink J, Auth J, Gozes I, Brenneman D. Oral prenatal treatment with peptides increases adult performance in a learning paradigm [abstract]. Am J Obstet Gynecol 2001;185:243.